1. Home
  2. POAI vs JXG Comparison

POAI vs JXG Comparison

Compare POAI & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • JXG
  • Stock Information
  • Founded
  • POAI 2002
  • JXG N/A
  • Country
  • POAI United States
  • JXG China
  • Employees
  • POAI N/A
  • JXG N/A
  • Industry
  • POAI Industrial Specialties
  • JXG
  • Sector
  • POAI Health Care
  • JXG
  • Exchange
  • POAI Nasdaq
  • JXG Nasdaq
  • Market Cap
  • POAI 4.9M
  • JXG 5.2M
  • IPO Year
  • POAI N/A
  • JXG N/A
  • Fundamental
  • Price
  • POAI $1.21
  • JXG $2.77
  • Analyst Decision
  • POAI Hold
  • JXG
  • Analyst Count
  • POAI 1
  • JXG 0
  • Target Price
  • POAI N/A
  • JXG N/A
  • AVG Volume (30 Days)
  • POAI 3.4M
  • JXG 139.0K
  • Earning Date
  • POAI 11-12-2024
  • JXG 12-06-2024
  • Dividend Yield
  • POAI N/A
  • JXG N/A
  • EPS Growth
  • POAI N/A
  • JXG N/A
  • EPS
  • POAI N/A
  • JXG 2.20
  • Revenue
  • POAI $1,484,223.00
  • JXG $38,490,872.00
  • Revenue This Year
  • POAI N/A
  • JXG N/A
  • Revenue Next Year
  • POAI $569.48
  • JXG N/A
  • P/E Ratio
  • POAI N/A
  • JXG $1.26
  • Revenue Growth
  • POAI N/A
  • JXG N/A
  • 52 Week Low
  • POAI $0.55
  • JXG $0.75
  • 52 Week High
  • POAI $3.76
  • JXG $8.51
  • Technical
  • Relative Strength Index (RSI)
  • POAI 54.24
  • JXG N/A
  • Support Level
  • POAI $1.16
  • JXG N/A
  • Resistance Level
  • POAI $1.42
  • JXG N/A
  • Average True Range (ATR)
  • POAI 0.36
  • JXG 0.00
  • MACD
  • POAI -0.00
  • JXG 0.00
  • Stochastic Oscillator
  • POAI 19.21
  • JXG 0.00

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About JXG JX Luxventure Limited Common Stock

JX Luxventure Group Inc, formerly JX Luxventure Ltd is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Airline tickets and tourism services, Software Solutions for Tourism Cross-border operation, and Tourism Cross-border Merchandise. The majority of the group revenue is generated from Tourism products.

Share on Social Networks: